Breaking News

Indena Strengthens Botanical Active Ingredients Supply Chain

Successfully completes registration of escin, in accordance with the REACH regulation

By: Contract Pharma

Contract Pharma Staff

Indena confirmed its move to improve the supply chain of escin and horse chestnut derivatives, successfully completing the registration of ESCIN (INCI:  ESCIN; EC # 229-880-6, CAS # 6805-41-0, Registration 01-2120757334-53-0000) in accordance with the REACH regulation (EC) No 1907/2006 as lead registrant.   According to the company, it is the only company which has completed the full registration, following the pre-registration stage which ended in 2018. As such, the company has generated the re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters